Stockreport

Precigen, Inc. (PGEN) Secures $125M to Accelerate PAPZIMEOS Commercialization [Yahoo! Finance]

Precigen, Inc.  (PGEN) 
Last precigen, inc. earnings: 3/2 04:05 pm Check Earnings Report
PDF Precigen, Inc. (NASDAQ:PGEN) is a biotechnology company developing precision genetic medicines for oncology, infectious diseases, and rare conditions. Its platforms inc [Read more]